Haystack Analytics

Haystack Analytics

Private
Mumbai, MaharashtraHealthcare & Life Scienceshttps://www.haystackanalytics.in/

Last Round

Early Funding

Mar 1, 2026

Est. Valuation

$70M

Total Funding Raised

$8.79M

Momentum Score

25 /100

Company Overview

Haystack Analytics is a health-tech company, spun out of IIT Bombay, that develops genomic diagnostic tools for the rapid and accurate identification of infectious diseases. The company's platform utilizes next-generation sequencing (NGS) and bioinformatics to detect a wide range of pathogens and identify antimicrobial resistance genes from a single sample. This enables healthcare providers to make faster, evidence-based treatment decisions, particularly in critical cases like sepsis and tuberculosis. Their 'Made in India' proprietary technology, including the infexnTM test, aims to make clinical genomics scalable, affordable, and accessible to diagnostic labs and hospitals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI, Edge Computing

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

genomic diagnosticsNext-Generation SequencingNGSinfectious disease diagnosticsbioinformatics platformantimicrobial resistance detectionAMR detectionpathogen identificationsepsis diagnosistuberculosis diagnosismolecular diagnosticsprecision medicinewhole-genome sequencingWGShealthtechedge computing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Haystack Analytics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Haystack Analytics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 1, 2026
Pre SeedJun 6, 2024
GrantOct 18, 2021

Key People

Founding team and executive leadership

Anirvan Chatterjee

Co-Founder And CEO

Founding Team

Haystack Analytics Investors

Notable investors and investment history

InvestorRounds
Nidhi PrayasGrant
1CrowdEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Omega TB is the only ICMR-approved TB WGS solution in India.

  • Mar 1, 2026

    New AI platform 'identifi-NGS' for human genomics in development.

Haystack Analytics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Haystack Analytics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Haystack Analytics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMumbai, Maharashtra
Employee Range207
Year Founded2018
Last FundingMar 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.